Key points are not available for this paper at this time.
Newborn screening (NBS) for hepatorenal tyrosinemia type I (HT1) based on a determination of succinylacetone is performed in countries worldwide. Recently, biallelic pathogenic variants in
Gramer et al. (Tue,) studied this question.